Published on
February 12, 2022
- 17:25 GMT
Aarca Research announces clinical validation of IHRA, first-of-its-kind early detection test for metabolic comorbidities
Aarca Research announced clinical validation of their non-invasive test’s accuracy for early detection of Type 2 Diabetes, Hypertension, and Dyslipidemia. BANGALORE, KARNATAKA, INDIA, February 12, 2022 /EINPresswire.com/ -- Aarca Research India Pvt Ltd …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Technology
...
